CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Canada

Invite Credit Card Holder to pay

Requester Details

Credit Card Holder Details

Company Details

Message to be included

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Canada”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Canada. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Canada. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

In 2016, Canada population was approximately at 36.3 million. The Canadian pharmaceutical industry is the 10th largest market with a share of 2% of the global market. In 2015, pharmaceutical sales were estimated at $22.1 billion. This rose to about $22.6 billion in 2016 and is forecast to increase to $25 billion in 2021, at a CAGR of 2%. Patented drugs accounted for 61.8% of the total sales in 2015. The medical device market in Canada was worth $8.7 billion in 2009, which increased to $11 billion in 2016. It is expected to grow at a CAGR of 4.2% from $11.5 billion in 2017 to $13.5 billion in 2021. The main segments ophthalmic devices, orthopedic devices, drug delivery devices, in vitro diagnostics and healthcare IT will drive market growth.

These positive trends can primarily be attributed to:

  • Increasing awareness regarding early disease detection and diagnosis
  • Advances in medical technology

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Canada, and includes:

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (Johnson & Johnson, Novartis, Teva, Apotex and Gilead) and profiles and SWOT analyses of the major players in the medical device market (Johnson & Johnson, Medtronic, Baxter, Fresenius and Sonova)
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the Canadian healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to:

  • Develop business strategies by understanding the trends shaping and driving the Canadian healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
  • Identify, understand, and capitalize on the opportunities and challenges in the Canadian healthcare market

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Executive Summary

3 Introduction

3.1 GlobalData Report Guidance

4 ...

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Executive Summary

3 Introduction

3.1 GlobalData Report Guidance

4 Overview of the Pharmaceutical and Medical Device Markets

4.1 Pharmaceutical Market

4.1.1 Market Overview

4.1.2 Pharmaceutical Imports and Exports

4.1.3 Supply Channels

4.1.4 Market Segments

4.1.5 Overview of Major Therapeutic Areas

4.1.6 Overview of Major Drug Classes

4.1.7 Major Players

4.2 Medical Device Market

4.2.1 Market Overview

4.2.2 Overview of Top Five Segments

4.2.3 Major Players

4.3 Market Drivers and Barriers

4.3.1 Drivers

4.3.2 Barriers

5 Market Access

5.1 Reimbursement and Payer Landscape

5.1.1 Overview of Healthcare System

5.1.2 Drug Reimbursement Process

5.1.3 Medical Device and Diagnostics Reimbursement Process

5.1.4 Overview of Insurance Providers

5.1.5 Patient Share in Healthcare Spending

5.1.6 Price Trend in Healthcare Services

5.1.7 Pricing Policies

5.2 Regulatory Landscape

5.2.1 Overview of Regulatory Agencies

5.2.2 Market Authorization Procedure for Pharmaceutical Products

5.2.3 Market Authorization Procedure for Medical Devices

5.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing

5.2.5 Licensing Process for Pharmaceutical Exports and Imports

5.2.6 Intellectual Property Rights

5.2.7 Clinical Trial Regulations

5.2.8 Pharmacy Regulations

5.2.9 Labeling and Packaging Regulations

6 Country Analysis

6.1 Political Environment

6.1.1 Political Structure

6.1.2 Analysis of the Current Political Environment

6.1.3 Healthcare Policy Initiatives

6.2 Economic Landscape

6.3 Economic Indicators

6.3.1 Gross Domestic Product

6.3.2 Gross National Income

6.3.3 Inflation

6.3.4 Currency Exchange Rate

6.3.5 Foreign Direct Investment

6.3.6 Foreign Exchange Reserves

6.3.7 Trade Balance

6.3.8 General Government Structural Balance

6.3.9 General Government Net Debt

6.3.10 Major Industries

6.4 Demographics

6.4.1 Population

6.4.2 Urban–Rural Share

6.4.3 Distribution by Age Group

6.4.4 Birth Rate

6.4.5 Mortality

6.4.6 Causes of Mortality

6.4.7 Health Status by Gender and Age

6.4.8 Education and Literacy

6.4.9 Employment

6.4.10 Disease Burden

6.5 Healthcare Infrastructure

6.5.1 Healthcare Facilities

6.5.2 Healthcare Parameters

6.5.3 Environmental Health

6.5.4 Healthcare Personnel

6.6 Healthcare Expenditure

6.6.1 Overview

6.6.2 Public–Private Sector Share

6.6.3 Major Components of Healthcare Spending

6.6.4 Spending in Science and Technology Research and Development

6.7 Trade Associations

6.7.1 Canadian Pharmacists Association (CPhA)

6.7.2 Canadian Association of Professional Regulatory Affairs

6.7.3 Canadian Society for Hospital Pharmacists

6.7.4 Canadian Generic Pharmaceutical Association

6.8 Trade Fairs

7 Opportunities and Challenges

7.1 Opportunities

7.2 Challenges

8 Appendix

8.1 Abbreviations

8.2 Bibliography

8.3 Research Methodology

8.3.1 Coverage

8.3.2 Secondary Research

8.3.3 Forecasts

8.3.4 Expert Panel

8.4 Contact Us

8.5 Disclaimer

List of tables

Table 1: Pharmaceutical Market, Canada, Revenue ($bn), 2009–2016

Table 2: Pharmaceutical Market, Canada, Revenue Forecast ($bn), 2017–2021

Table 3: Pharmaceutical Market, Canada, Pharmaceutical ...

Table 1: Pharmaceutical Market, Canada, Revenue ($bn), 2009–2016

Table 2: Pharmaceutical Market, Canada, Revenue Forecast ($bn), 2017–2021

Table 3: Pharmaceutical Market, Canada, Pharmaceutical Spending (% of health spending), 2009–2015

Table 4: Pharmaceutical Market, Canada, Pharmaceutical Exports and Imports ($bn), 2009–2016

Table 5: Pharmaceutical Market, Canada, Average Price Generic Drug vs. Branded Drug, 2009–2016

Table 6: Pharmaceutical Market, Biologics, Canada, Approved Biologics, 2016

Table 7: Pharmaceutical Market, Canada, Over-the-Counter Drug Market Revenue ($bn), 2009–2016

Table 8: Pharmaceutical Market, Canada, Sales of Patented Drug Products by Major Therapeutic Class ($bn), 2015

Table 9: Pharmaceutical Market, Canada, Major Drug Classes by Annual Growth Rate (%), 2012–2015

Table 10: Pharmaceutical Market, Johnson & Johnson, Canada, Major Products, 2016

Table 11: Pharmaceutical Market, Johnson & Johnson, Planned Filings, 2017–2020

Table 12: Pharmaceutical Market, Novartis, Canada, Major Products, 2017

Table 13: Pharmaceutical Market, Novartis, Planned Filings, 2017–2020

Table 14: Pharmaceutical Market, Teva, Late-Stage Pipeline, 2017

Table 15: Pharmaceutical Market, Gilead, Major Products, 2017

Table 16: Pharmaceutical Market, Gilead, Global, Late-Stage Pipeline, 2017

Table 17: Medical Device Market, Canada, Revenue ($bn), 2009–2016

Table 18: Medical Device Market, Canada, Revenue Forecast ($bn), 2017–2021

Table 19: Medical Device Market, Canada, Revenue ($bn) and Market Share ($bn) by Segment, 2016

Table 20: Orthopedic Devices Market, Canada, Revenue ($bn), 2009–2016

Table 21: Orthopedic Devices Market, Canada, Revenue ($m) and Market Share (%) of Major Companies, 2016

Table 22: Ophthalmic Devices Market, Canada, Revenue ($bn), 2009–2016

Table 23: Ophthalmic Devices Market, Canada, Revenue ($m) and Market Share (%) of Major Companies, 2016

Table 24: Drug Delivery Devices Market, Canada, Revenue ($bn), 2009–2016

Table 25: Ophthalmic Devices Market, Canada, Revenue ($m) and Market Share (%) of Major Companies, 2016

Table 26: Cardiovascular Devices Market, Canada, Revenue of Major Players ($m), 2009–2016

Table 27: IVD Market, Canada, Revenue ($m) and Market Share (%) of Major Companies, 2015

Table 28: IVD Market, Canada, Revenue ($bn), 2009–2016

Table 29: Healthcare IT Market, Canada, Revenue ($m) and Market Share (%) of Major Companies, 2016

Table 30: Medical Device Market, Canada, Revenue ($m) of Major Companies, 2012

Table 31: Medical Device Market, Johnson & Johnson, Major Medical Device Sales, 2016

Table 32: Medical Device Market, Medtronic, Major Products, 2016

Table 33: Medical Device Market, Baxter, Global, Major Products, 2017

Table 34: Medical Device Market, Fresenius Medical Care, Global, Major Products, 2016

Table 35: Medical Device Market, Sonova, Global, Major Products, 2017

Table 36: Market Access, Canada, Out-of-Pocket Expenditure (% of total expenditure on health), 2009–2016

Table 37: Market Access, Canada, Annual Rate of Change (%), Patented Medicines Price Index, 2009–2015

Table 38: Market Access, Canada, Average Ratio of International Price to Canadian Price, 2009–2015

Table 39: Market Access, Target Review Times for New Drug Submissions, Canada, 2016

Table 40: Market Access, Classes of Medical Devices, 2016

Table 41: Economic Indicators, Canada, Gross Domestic Product per Capita ($), 2009–2016

Table 42: Economic Indicators, Canada, Gross Domestic Product per Capita Forecast ($), 2017–2021

Table 43: Economic Indicators, Canada, Gross Domestic Product Annual Growth (%), 2009–2016

Table 44: Economic Indicators, Canada, Gross Domestic Product Annual Growth Forecast (%), 2017–2021

Table 45: Economic Indicators, Canada, Gross National Income per Capita ($), 2009–2016

Table 46: Economic Indicators, Canada, Average Consumer Price Index, 2009–2016

Table 47: Economic Indicators, Canada, Average Consumer Price Annual Change (%), 2009–2016

Table 48: Economic Indicators, Canada, Currency Exchange Rate (CAD per $), 2009–2016

Table 49: Economic Indicators, Canada, Foreign Direct Investment ($bn), 2009–2015

Table 50: Economic Indicators, Canada, Foreign Exchange Reserves ($bn), 2009–2016

Table 51: Economic Indicators, Canada, Imports of Goods and Services ($bn), 2009–2016

Table 52: Economic Indicators, Canada, Exports of Goods and Services ($bn), 2009–2016

Table 53: Economic Indicators, Canada, Government Structural Balance ($bn), 2009–2016

Table 54: Economic Indicators, Canada, General Government Net Debt ($bn), 2009–2016

Table 55: Economic Indicators, Canada, Major Industries by Gross Value Added (percentage of GDP), 2016

Table 56: Demographics, Canada, Population (million), 2009–2016

Table 57: Demographics, Canada, Population (million), 2017–2021

Table 58: Demographics, Canada, Urban–Rural Population Share (%), 2009–2016

Table 59: Demographics, Canada, Population Distribution by Age Group (%), 2009–2016

Table 60: Demographics, Canada, Population Distribution by Age Group Forecast (%), 2017–2021

Table 61: Demographics, Canada, Births (per 1,000 population), 2009–2015

Table 62: Demographics, Canada, Mortality (per 1,000 population), 2009–2015

Table 63: Demographics, Canada, Major Causes of Mortality, 2015

Table 64: Demographics, Canada, Infant Mortality (per 1,000 live births), 2009–2016

Table 65: Demographics, Canada, Immunization Rate (%), 2009–2016

Table 66: Demographics, Canada, Major Causes of Male Mortality, 2015

Table 67: Demographics, Canada, Major Causes of Female Mortality, 2015

Table 68: Demographics, Canada, Gender Ratio (M/F), 2009–2016

Table 69: Demographics, Canada, Life Expectancy at Birth (years), 2009–2016

Table 70: Demographics, Canada, Part-Time and Full-Time University Students (‘000), 2009–2015

Table 71: Demographics, Canada, Unemployment Rate (%), 2009–2016

Table 72: Demographics, Canada, Most Frequently Diagnosed Diseases (‘000), 2015

Table 73: Demographics, Canada, Disability-Adjusted Life Years by Major Disease (‘000), 2015

Table 74: Healthcare Infrastructure, Canada, Number of Hospitals, 2009–2015

Table 75: Healthcare Infrastructure, Canada, Diagnostic Equipment (per million population), 2009–2015

Table 76: Healthcare Infrastructure, Canada, Hospital Beds (per 1,000 population), 2009–2015

Table 77: Healthcare Infrastructure, Canada, Acute Care Hospital Beds (per 1,000 population), 2009–2015

Table 78: Healthcare Infrastructure, Canada, Psychiatric Hospital Beds (per 1,000 population), 2009–2015

Table 79: Healthcare Infrastructure, Canada, PM2.5 (µg per m3), 2009–2015

Table 80: Healthcare Infrastructure, Canada, CO2 Emissions (million tons), 2009–2015

Table 81: Healthcare Infrastructure, Canada, Physicians (per 1,000 population), 2009–2015

Table 82: Healthcare Infrastructure, Canada, Dentists, 2009–2015

Table 83: Healthcare Infrastructure, Canada, Pharmacists, 2009–2015

Table 84: Healthcare Infrastructure, Canada, Nurses (per 1,000 population), 2009–2015

Table 85: Healthcare Expenditure, Canada, Healthcare Expenditure as Percentage of GDP (%), 2009–2016

Table 86: Healthcare Expenditure, Canada, Healthcare Expenditure ($bn), 2014–2019

Table 87: Healthcare Expenditure, Canada, Public–Private Share (%), 2009–2015

Table 88: Healthcare Expenditure, Canada, Major Components of Healthcare Spending (%), 2014

Table 89: Healthcare Expenditure, Canada, Share of Financing Agents (%), 2016

Table 90: Healthcare Expenditure, Canada, R&D Expenditure as Percentage of GDP (%), 2009–2015

Table 91: Healthcare Expenditure, Canada, Major Healthcare Trade Fairs, 2017

List of figures

Figure 1: Pharmaceutical Market, Canada, Revenue ($bn), 2009–2021

Figure 2: Medical Device Market, Canada, Revenue ($bn), 2009–2021

Figure 3: Country Profile, Canada, 2017 ...

Figure 1: Pharmaceutical Market, Canada, Revenue ($bn), 2009–2021

Figure 2: Medical Device Market, Canada, Revenue ($bn), 2009–2021

Figure 3: Country Profile, Canada, 2017

Figure 4: Pharmaceutical Market, Canada, Revenue ($bn), 2009–2016

Figure 5: Pharmaceutical Market, Canada, Revenue Forecast ($bn), 2017–2021

Figure 6: Pharmaceutical Market, Canada, Pharmaceutical Spending as Percentage of Health Spending (%), 2009–2015

Figure 7: Pharmaceutical Market, Canada, Pharmaceutical Exports and Imports ($bn), 2009–2016

Figure 8: Pharmaceutical Market, Canada, Supply Channels, 2016

Figure 9: Pharmaceutical Market, Canada, Average Price Generic Drug vs. Branded Drug, 2009–2016

Figure 10: Pharmaceutical Market, Canada, Over-the-Counter Drug Market Revenue ($bn), 2009–2016

Figure 11: Pharmaceutical Market, Canada, Sales of Patented Drug Products by Major Therapeutic Class, 2015

Figure 12: Pharmaceutical Market, Canada, Major Drug Classes by Annual Growth Rate (%), 2012–2015

Figure 13: Medical Device Market, Canada, Revenue ($bn), 2009–2016

Figure 14: Medical Device Market, Canada, Revenue Forecast ($bn), 2017–2021

Figure 15: Medical Device Market, Canada, Revenue by Segment ($bn), 2016

Figure 16: Orthopedic Devices Market, Canada, Revenue ($bn), 2009–2016

Figure 17: Orthopedic Devices Market, Canada, Market Share of Major Players (%), 2016

Figure 18: Ophthalmic Devices Market, Canada, Revenue ($bn), 2009–2016

Figure 19: Ophthalmic Devices Market, Canada, Market Share of Major Players (%), 2016

Figure 20: Drug Delivery Devices Market, Canada, Revenue ($bn), 2009–2016

Figure 21: Drug Delivery Devices Market, Canada, Market Share of Major Players (%), 2016

Figure 22: In Vitro Diagnostics Market, Canada, Revenue ($bn), 2009–2016

Figure 23: In Vitro Diagnostics Market, Canada, Market Share of Major Players (%), 2015

Figure 24: Healthcare IT Market, Canada, Revenue ($bn), 2009–2016

Figure 25: Healthcare IT Market, Canada, Market Share of Major Companies (%), 2016

Figure 26: Medical Device Market, Canada, Revenue of Major Companies ($m), 2012

Figure 27: Pharmaceutical Market, Canada, Drivers and Barriers, 2017

Figure 28: Market Access, Canada, Reimbursement Process, 2017

Figure 29: Market Access, Canada, Medical Device and Diagnostics Reimbursement Process, 2017

Figure 30: Market Access, Canada, Out-of-Pocket Expenditure (% of total expenditure on health), 2009–2016

Figure 31: Market Access, Canada, Annual Rate of Change (%), Patented Medicines Price Index, 2009–2015

Figure 32: Market Access, Canada, Average Ratio of International Price to Canadian Price, 2009–2015

Figure 33: Health Products and Food Branch, Organization Chart, Canada, 2015

Figure 34: New Drug Approval Process, Canada, 2017

Figure 35: Patent Approval Process, Canada, 2015

Figure 36: Clinical Trial Regulation Process, Canada, 2016

Figure 37: Economic Indicators, Canada, Gross Domestic Product per Capita ($), 2009–2016

Figure 38: Economic Indicators, Canada, Gross Domestic Product per Capita Forecast ($), 2017–2021

Figure 39: Economic Indicators, Canada, Gross Domestic Product Annual Growth (%), 2009–2016

Figure 40: Economic Indicators, Canada, Gross Domestic Product Annual Growth Forecast (%), 2017–2021

Figure 41: Economic Indicators, Canada, Gross National Income per Capita ($), 2009–2016

Figure 42: Economic Indicators, Canada, Average Consumer Price Index, 2009–2016

Figure 43: Economic Indicators, Canada, Average Consumer Price Annual Change (%), 2009–2016

Figure 44: Economic Indicators, Canada, Currency Exchange Rate (CAD per $), 2009–2016

Figure 45: Economic Indicators, Canada, Foreign Direct Investment ($bn), 2009–2015

Figure 46: Economic Indicators, Canada, Foreign Exchange Reserves ($bn), 2009–2016

Figure 47: Economic Indicators, Canada, Imports of Goods and Services ($bn), 2009–2016

Figure 48: Economic Indicators, Canada, Exports of Goods and Services ($bn), 2009–2016

Figure 49: Economic Indicators, Canada, Government Structural Balance ($bn), 2009–2016

Figure 50: Economic Indicators, Canada, General Government Net Debt ($bn), 2009–2016

Figure 51: Economic Indicators, Canada, Major Industries by Gross Value Added (percentage of GDP), 2016

Figure 52: Demographics, Canada, Population (million), 2009–2016

Figure 53: Demographics, Canada, Population (million), 2017–2021

Figure 54: Demographics, Canada, Urban–Rural Population Share (%), 2009–2016

Figure 55: Demographics, Canada, Population Distribution by Age Group (%), 2009–2016

Figure 56: Demographics, Canada, Population Distribution by Age Group Forecast (%), 2017–2021

Figure 57: Demographics, Canada, Births (per 1,000 population), 2009–2015

Figure 58: Demographics, Canada, Mortality (per 1,000 population), 2009–2015

Figure 59: Demographics, Canada, Major Causes of Mortality, 2015

Figure 60: Demographics, Canada, Infant Mortality (per 1,000 live births), 2009–2016

Figure 61: Demographics, Canada, Immunization Rate (%), 2009–2016

Figure 62: Demographics, Canada, Major Causes of Male Mortality, 2015

Figure 63: Demographics, Canada, Major Causes of Female Mortality, 2015

Figure 64: Demographics, Canada, Gender Ratio (M/F), 2009–2016

Figure 65: Demographics, Canada, Life Expectancy at Birth (years), 2009–2016

Figure 66: Demographics, Canada, Part-Time and Full-Time University Students (‘000), 2009–2015

Figure 67: Demographics, Canada, Unemployment Rate (%), 2009–2016

Figure 68: Demographics, Canada, Patients (‘000s), 2015–2016

Figure 69: Demographics, Canada, Disability-Adjusted Life Years by Major Disease (‘000), 2015

Figure 70: Healthcare Infrastructure, Canada, Number of Hospitals, 2009–2015

Figure 71: Healthcare Infrastructure, Canada, Diagnostic Equipment (per million population), 2009–2015

Figure 72: Healthcare Infrastructure, Canada, Hospital Beds (per 1,000 population), 2009–2015

Figure 73: Healthcare Infrastructure, Canada, Acute Care Hospital Beds (per 1,000 population), 2009–2015

Figure 74: Healthcare Infrastructure, Canada, Psychiatric Hospital Beds (per 1,000 population), 2009–2015

Figure 75: Healthcare Infrastructure, Canada, PM2.5 (µg per m3), 2009–2015

Figure 76: Healthcare Infrastructure, Canada, CO2 Emissions (million tons), 2009–2015

Figure 77: Healthcare Infrastructure, Canada, Physicians, 2009–2015

Figure 78: Healthcare Infrastructure, Canada, Dentists, 2009–2015

Figure 79: Healthcare Infrastructure, Canada, Pharmacists, 2009–2015

Figure 80: Healthcare Infrastructure, Canada, Nurses, 2009–2015

Figure 81: Healthcare Expenditure, Canada, Healthcare Expenditure as Percentage of GDP (%), 2009–2016

Figure 82: Healthcare Expenditure, Canada, Healthcare Expenditure ($bn), 2014–2019

Figure 83: Healthcare Expenditure, Canada, Public–Private Share (%), 2009–2015

Figure 84: Healthcare Expenditure, Canada, Major Components of Healthcare Spending (%), 2014

Figure 85: Healthcare Expenditure, Canada, Share of Financing Agents (%), 2016

Figure 86: Healthcare Expenditure, Canada, R&D Expenditure as Percentage of GDP (%), 2009–2015

Figure 87: Healthcare Market, Canada, Opportunities and Challenges, 2017

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Saved reports

GlobalData has been instrumental in ensuring we are well informed about our clients business, their key products

  Deloitte Switzerland